Medicare Weight-Loss Drug Coverage in 2027: What You'll Actually Pay
Original Medicare, Medicare Advantage, and the $50 GLP-1 program: what to check before choosing next year's coverage.
PoundsPunch | October 2026
Medicare's $50-a-month program for certain GLP-1 medicines, including Wegovy and Zepbound, is continuing into 2027. Before you switch plans to get it, check whether you qualify: you may not need a different plan at all.
What this means for you
Already getting a GLP-1 through your Medicare drug plan? Check that plan's 2027 coverage and costs. Do not assume you can replace it with the $50 Bridge benefit.
Your plan does not cover treatment for weight loss? The Medicare GLP-1 Bridge may offer certain medicines for $50 a month if you meet its rules and get approval. Being turned down by your plan does not automatically qualify you.
You do not need Medicare Advantage to get the $50 benefit. If you have Original Medicare, you need a separate prescription drug plan, called Part D. If you have Medicare Advantage, check that your plan includes prescription drug coverage. You still need to meet the Bridge program's eligibility rules.
Budget for the Bridge separately. Its $50 payments do not count toward the $2,400 yearly limit on what you spend on covered Part D drugs in 2027.
This fall's Medicare open enrollment ends December 7, 2026. Changes made during that window generally take effect January 1, 2027.
Start with the cards in your wallet
Original Medicare: a separate plan for prescriptions
Original Medicare is the government-run hospital and medical coverage, known as Parts A and B. You usually show your red, white, and blue Medicare card at the doctor's office. For prescriptions, you can add a separate Part D drug plan and use its card at the pharmacy.
To check a medicine, look at that drug plan's website or call the number on its card. Its 'formulary' is simply its covered-drug list. A Medigap policy helps with some Original Medicare medical bills; it is not a substitute for a drug plan.
Medicare Advantage: usually one plan for both
Medicare Advantage provides your Medicare benefits through a private insurer. Most plans include prescription coverage, so you generally use the plan's card for both medical care and prescriptions.
On its website, look for prescription information to check your medicine, and the doctor list to check your medical providers. A plan can include your doctor but not your drug, or the other way around.
Medicare Advantage members keep their red, white, and blue card, too. Having that card does not tell you which arrangement you use. Your secure Medicare account can show your current coverage.
How Medicare weight-loss drug coverage works in 2027
Regular Part D generally does not cover medicines prescribed solely for weight loss. Some of those medicines can be covered for other approved uses, such as Wegovy to lower heart attack or stroke risk in certain patients, or Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity. Your plan still checks whether its requirements are met.
The Bridge is a separate, temporary program for weight management. It began July 1, 2026, and runs through December 31, 2027. Your insurer does not have to sign up for you to use it. Our earlier article, The $50 Bridge: Medicare's First Real Door Into Weight-Loss Drugs, explains the background.
Who can get the $50 prescription?
The Bridge is not open to everyone whose doctor recommends a weight-loss drug. Adults must meet one of these starting points, based on body mass index, or BMI, a measure calculated from height and weight:
BMI of 35 or higher.
BMI of 30 or higher, plus a specified type of heart failure, blood pressure that stays high despite treatment, or kidney disease at stage 3a or higher.
BMI of 27 or higher, plus prediabetes, a previous heart attack or stroke, or blocked arteries in the arms or legs that cause symptoms.
Your doctor must check the exact definitions. For example, the heart-failure category is the type called 'heart failure with preserved ejection fraction,' not every kind of heart failure. Treatment must also include an ongoing nutrition and physical-activity program. For people already taking a GLP-1, the BMI rules apply when treatment began; losing weight does not by itself disqualify you.
Some conditions rule out the Bridge even when you meet those BMI requirements: type 2 diabetes, moderate-to-severe obstructive sleep apnea, and MASH, an inflammatory fatty-liver disease, with moderate-to-advanced scarring but without cirrhosis. That's because Medicare drug plans can already cover certain GLP-1 medicines to treat these conditions.
Heart disease does not automatically rule you out. You may qualify for the Bridge when the prescription is for weight management and you meet the other rules. But if the medicine is prescribed to lower your risk of a heart attack or stroke, your regular drug plan handles it, even when weight loss is also a goal. Your doctor must document the actual reason for treatment; this is not a choice between two prices.
For prescriptions that belong with your regular drug plan, a denial does not make the Bridge available instead. Ask your doctor and plan about a coverage exception or appeal, which means asking them to reconsider the decision.
The current Bridge list includes Foundayo tablets, Wegovy injections and tablets, and Zepbound KwikPen. Zepbound's single-dose pens and vials are not included. Ask about the exact product, not just the brand name.
What happens at the pharmacy
Your doctor sends the prescription to the pharmacy. The pharmacy submits it to the Bridge, then asks your doctor's office to complete the approval paperwork. This is called 'prior authorization': permission before the program pays. You do not need your regular drug plan to turn you down first.
The pharmacy may ask for your Medicare Number to process the prescription. Humana currently handles the Bridge's payments and approvals, but you do not need to buy a Humana insurance plan.
You receive an approval letter by mail. Under current rules, approval covers refills and dose changes through December 31, 2027, unless you change GLP-1 medicines. You must still remain eligible. Bridge purchases will not appear on your regular Part D statement of prescription costs.
The $50 payment and the $2,400 limit are separate
In 2027, the yearly limit on your spending for covered Part D drugs is $2,400, up from $2,100 in 2026. It applies to separate drug plans and Medicare Advantage plans that include drug coverage. It does not cap all your healthcare bills, and monthly insurance premiums do not count toward it.
Before reaching that limit, your costs depend on your plan and any financial help you receive. Your plan may have a deductible, the amount you pay before it starts sharing certain drug costs. The maximum for 2027 is $700; some plans charge less or none.
Bridge prescriptions are separate. You pay $50 for each 28- or 30-day supply, depending on the medicine, without a Part D deductible. Even after you reach the $2,400 limit on your other covered drugs, you still pay $50 for each Bridge refill.
Extra Help, Medicare's assistance with drug costs for people with limited income and resources, does not lower that $50 charge. You also cannot spread it across months through the Medicare Prescription Payment Plan.
Medicare's negotiated prices for Ozempic, Rybelsus, and Wegovy start January 1, 2027. Those are not the prices every patient pays, and they do not remove coverage requirements. Ask what your prescription will cost under your plan.
Linda and Robert: two different prescriptions
These are fictional examples. Their different medical situations explain the different results, not whether Original Medicare or Medicare Advantage is better.
Linda has Original Medicare plus a separate Part D plan. Her BMI is 36, she has none of the conditions that exclude someone from the Bridge, and she has never had a GLP-1 paid for by Part D. Her doctor checks the remaining rules and requests Bridge approval for weight management. She does not need Medicare Advantage to pursue the $50 benefit, but still needs to compare her other drug costs and pharmacy.
Robert has Medicare Advantage with drug coverage, obesity, and moderate-to-severe obstructive sleep apnea. His doctor prescribes Zepbound for the sleep apnea. He must check his plan's approval rules and price; the Bridge is not available for this prescription. If the plan says no, he and his doctor can ask it to reconsider. Switching to Original Medicare would not change why he needs the medicine.
Before you keep or change your plan
Read your Annual Notice of Change, the document your plan sends in the fall explaining next year's changes. Then compare 2027 plans on Medicare's plan comparison tool using your actual medicines, doses, and pharmacies. Check these four things:
Your medicine: Does the plan cover the exact drug and version for your condition? What does your doctor need to submit for approval?
Your total bill: Add the monthly insurance payments, deductible, drug costs, and any separate Bridge prescriptions. Use prices for the pharmacy you will actually visit.
Your doctors: With Medicare Advantage, check that your doctors and hospitals accept that specific plan, and find out what visits and hospital stays would cost you.
A change of plan: Ask whether you would need new drug approvals. Before leaving Medicare Advantage, check whether you can buy the Medigap policy you want. Fall open enrollment does not guarantee that a Medigap insurer must accept you.
Use documents for your specific 2027 plan, not a general insurer webpage. A medicine appearing on a covered-drug list does not mean it is covered for every patient or every use.
Two things we still do not know
How past GLP-1 use will affect 2027 eligibility. CMS, the agency that runs Medicare, checks whether your Part D plan has already paid for a GLP-1. In 2026, it checks that year's prescriptions. As of October 31, its published guidance still does not say how far back it will check in 2027. Do not assume January 1 gives you a fresh start.
What happens after 2027. The Bridge ends December 31, 2027, under the current schedule. CMS says its broader program, BALANCE, will not start in Medicare in 2027. Continued access after the Bridge ends is not yet guaranteed.
For help with your own choices, contact your State Health Insurance Assistance Program, or SHIP, for free, unbiased Medicare counseling, or call 1-800-MEDICARE. Bring your medication list and plan documents. A price in an advertisement cannot tell you whether a plan fits your life.
Important note
PoundsPunch is not an insurance agency or brokerage and does not recommend a specific plan for you. This article provides general information, not personal insurance, medical, financial, or legal advice. It is not affiliated with or endorsed by Medicare or CMS. Rules and costs can change. Before choosing or changing coverage, confirm the details with the plan and consult SHIP, Medicare, or a licensed insurance professional. Discuss treatment with your clinician. The patient stories are fictional.
References
Official sources checked October 31, 2026. Earlier PoundsPunch coverage linked in the article provides background; the current rules come from the sources below.
Understanding your coverage and choosing a plan
Medicare: Your coverage options.
Medicare: How to get Medicare services.
Medicare: Your Medicare Card.
Medicare: Open Enrollment.
Medicare: Plan Annual Notice of Change (ANOC).
Medicare: Find a Medicare plan.
Medicare: When can I buy a Medigap policy?.
SHIP National Technical Assistance Center: Get Medicare Help from Your Local SHIP Program.
Weight-loss drugs, eligibility, and 2027 costs
Centers for Medicare & Medicaid Services (CMS): Medicare GLP-1 Bridge.
Medicare: Weight loss drugs.
CMS: Information for Part D Plans. Includes exclusions and the unresolved 2027 look-back period.
Medicare: How much does Medicare drug coverage cost?.
Comments